Shockwave Medical Inc. [SWAV] stock is trading at $334.01, up 1.33%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SWAV shares have gain 0.95% over the last week, with a monthly amount glided 1.66%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Shockwave Medical Inc. [NASDAQ: SWAV] stock has seen the most recent analyst activity on April 05, 2024, when Wolfe Research downgraded its rating to a Peer Perform. Previously, CL King started tracking the stock with Buy rating on March 27, 2024, and set its price target to $368. On September 29, 2023, UBS initiated with a Neutral rating and assigned a price target of $218 on the stock. Morgan Stanley upgraded its rating to a Overweight and increased its price target to $335 on July 10, 2023. Needham started tracking with a Buy rating for this stock on March 15, 2023, and assigned it a price target of $240. In a note dated December 16, 2022, Deutsche Bank initiated an Buy rating and provided a target price of $285 on this stock.
Shockwave Medical Inc. [SWAV] stock has fluctuated between $157.00 and $331.58 over the past year. Currently, Wall Street analysts expect the stock to reach $258.17 within the next 12 months. Shockwave Medical Inc. [NASDAQ: SWAV] shares were valued at $334.01 at the most recent close of the market. An investor can expect a potential drop of -22.71% based on the average SWAV price forecast.
Analyzing the SWAV fundamentals
Shockwave Medical Inc. [NASDAQ:SWAV] reported sales of 787.97M for the trailing twelve months, which represents a growth of 35.85%. Gross Profit Margin for this corporation currently stands at 0.87% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.21%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.25 and Total Capital is 0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 333.90 points at the first support level, and at 333.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 334.20, and for the 2nd resistance point, it is at 334.39.
Ratios To Look Out For
For context, Shockwave Medical Inc.’s Current Ratio is 13.81. Further, the Quick Ratio stands at 12.61, while the Cash Ratio is 3.05. Considering the valuation of this stock, the price to sales ratio is 15.91, the price to book ratio is 16.66 and price to earnings (TTM) ratio is 78.23.
Transactions by insiders
Recent insider trading involved Zacharias Isaac, President, CCO, that happened on Mar 26 ’24 when 4000.0 shares were sold. Director, FRANCIS LAURA completed a deal on Mar 26 ’24 to sell 1500.0 shares. Meanwhile, Director WATKINS FRANK T sold 2000.0 shares on Mar 06 ’24.
